ClinConnect ClinConnect Logo
Search / Trial NCT06879665

TANDem-2: Closing the Gap to Interventions for TAND

Launched by VRIJE UNIVERSITEIT BRUSSEL · Mar 13, 2025

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

Caregiver Well Being Psychological Flexibility Acceptance And Commitment Therapy (Act) Tuberous Sclerosis Complex (Tsc) Tsc Associated Neuropsychiatric Disorders (Tand)

ClinConnect Summary

The investigators hypothesize that an innovative, ultra-brief caregiver wellbeing intervention developed for caregivers of children with developmental disabilities can be adapted as a universal caregiver wellbeing intervention in tuberous sclerosis complex (TSC), that it can be delivered feasibly in an online modality, and will result in changes in key caregiver wellbeing factors. To test these hypotheses, the researchers will adapt the 3-session 'Well-Beans for Caregivers' program through a participatory method with the TAND consortium (the TAND consortium is an international group of clin...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult caregiver of an individual with Tuberous Sclerosis Complex (TSC) of any age
  • Exclusion Criteria:
  • Not an adult caregiver of an individual with TSC

Trial Officials

Anna Jansen, MD, PhD

Principal Investigator

Vrije Universiteit Brussel

Petrus J de Vries, MD PhD

Principal Investigator

University of Cape Town

About Vrije Universiteit Brussel

The Vrije Universiteit Brussel (VUB) is a distinguished research university located in Brussels, Belgium, known for its commitment to innovative education and cutting-edge research across various disciplines. As a clinical trial sponsor, VUB actively engages in advancing medical knowledge and improving patient care through rigorous scientific investigations. The university fosters collaborations with healthcare institutions and industry partners, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements. VUB's research initiatives are driven by a multidisciplinary approach, leveraging expertise from fields such as medicine, health sciences, and biomedical engineering to address pressing health challenges and contribute to the development of novel therapies.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported